Amphastar at 15th Annual Needham: Mnkd purchased $20M in '15
Apr 18, 2016 19:39:01 GMT -5
esstan2001, daduke38, and 5 more like this
Post by lakers on Apr 18, 2016 19:39:01 GMT -5
Amphastar at 15th Annual Needham Healthcare Conference
April 13, 2016, SLide 5/20
Recombinant Human Insulin (RHI)
− RHI from AFP is used in our pipeline
− 2014 supply agreement with MannKind to supply RHI for Afrezza®
− Agreement specifies minimum annual sales of 24 million euros annually for 5 years from 2015 -
2019
− Further amounts may be purchased
− 2015 Option Agreement to supply additional quantities in 2016-2019
− If MannKind chooses not to exercise its option, they pay a cancelation fee
− Bankruptcy would terminate contract
− Several other customers currently purchasing R&D quantities for filings outside of the US
− One customer buying production quantities outside of the US
− MannKind purchased $20 million in 2015
− Mutually agreed to take a lower quantity than contractually required in 2015
ir.amphastar.com/events.cfm
April 13, 2016, SLide 5/20
Recombinant Human Insulin (RHI)
− RHI from AFP is used in our pipeline
− 2014 supply agreement with MannKind to supply RHI for Afrezza®
− Agreement specifies minimum annual sales of 24 million euros annually for 5 years from 2015 -
2019
− Further amounts may be purchased
− 2015 Option Agreement to supply additional quantities in 2016-2019
− If MannKind chooses not to exercise its option, they pay a cancelation fee
− Bankruptcy would terminate contract
− Several other customers currently purchasing R&D quantities for filings outside of the US
− One customer buying production quantities outside of the US
− MannKind purchased $20 million in 2015
− Mutually agreed to take a lower quantity than contractually required in 2015
ir.amphastar.com/events.cfm